Valuation: BioNTech SE

Market Cap 19.84B 22.59B 18.45B 16.93B 31.81B 2,175B 32.3B 219B 85.6B 1,070B 84.8B 82.98B 3,698B P/E 2026 *
-17.9x
P/E 2027 * -17.2x
Enterprise Value 8.99B 10.23B 8.36B 7.67B 14.41B 985B 14.63B 99.24B 38.77B 484B 38.41B 37.58B 1,675B EV / Sales 2026 *
4.15x
EV / Sales 2027 * 4.73x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day-2.97%
1 week-2.35%
Current month-4.00%
1 month-0.98%
3 months-15.29%
6 months-22.98%
Current year-6.17%
1 week 88.92
Extreme 88.92
93.9
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/5/26 Free

Executive/Senior Manager

22,655 0.0094%
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
-2.97%-2.35%-22.03%-16.54% 22.59B
+0.93%+6.97%+62.83%+67.97% 57.28B
-1.92%+6.03%+43.68%+84.56% 54.99B
-0.46%-1.29%+3.28%+422.58% 23.18B
-0.36%+5.73%+30.99%-3.58% 20.46B
-1.34%+0.51%+25.02%-30.27% 17.56B
-1.44%+5.67%+32.54%+544.11% 15.67B
-1.30%-5.02%+165.62%+291.37% 14.46B
-0.50%-0.98%+23.62%+178.38% 13.92B
+0.21%-1.62%+82.01%+164.74% 12.55B
Average -0.92%+0.99%+44.76%+170.33% 25.27B
Weighted average by Cap. -0.82%+1.91%+43.21%+137.13%

Financials

2026 *2027 *
Net sales 2.17B 2.47B 2.02B 1.85B 3.48B 238B 3.53B 23.94B 9.35B 117B 9.27B 9.07B 404B 2.23B 2.54B 2.07B 1.9B 3.58B 245B 3.63B 24.63B 9.62B 120B 9.53B 9.33B 416B
Net income -1.04B -1.19B -969M -889M -1.67B -114B -1.7B -11.51B -4.5B -56.18B -4.45B -4.36B -194B -1.16B -1.33B -1.08B -994M -1.87B -128B -1.9B -12.86B -5.02B -62.78B -4.98B -4.87B -217B
Net Debt -10.85B -12.36B -10.09B -9.26B -17.4B -1,190B -17.67B -120B -46.83B -585B -46.39B -45.39B -2,023B -9.29B -10.57B -8.64B -7.92B -14.89B -1,018B -15.12B -103B -40.06B -501B -39.69B -38.83B -1,731B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
24/07/26 USD 89.33 -2.97% 886,104
23/07/26 USD 92.06 +0.25% 539,216
22/07/26 USD 91.83 -0.54% 508,360
21/07/26 USD 92.33 +0.18% 696,991
20/07/26 USD 92.16 +0.74% 687,738
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
78.46EUR
Average target price
106.88EUR
Spread / Average Target
+36.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock